Search This Blog

Monday, June 5, 2023

Masimo: FDA 510(k) Clears Radius Vital Signs Monitor

 Transformational, Versatile, Patient-worn, Continuous Vital Signs Monitor Features Wide Range of Physiological Measurements on a Compact, Scalable Platform

 

Masimo Corporation (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on a modular platform, Radius VSM allows clinicians to monitor a wide variety of physiological measurements, including Masimo SET® pulse oximetry, noninvasive blood pressure, temperature, respiration rate, and electrocardiography (ECG). By combining the reliability and accuracy of larger bedside monitors with the comfort and freedom of a wearable device, Radius VSM allows ambulation and movement while ensuring patients remain continuously monitored. With its flexibility and expandability, Radius VSM can be easily scaled to match each patient’s unique monitoring needs and level of acuity, across the continuum of care, and to accommodate surges in patient volume.

https://www.biospace.com/article/releases/masimo-announces-fda-510-k-clearance-of-radius-vsm-/


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.